Jiangsu Hengrui Medicine Co.,Ltd.’s Net Profit Rose 2.1% in First Quarter of 2023

Jiangsu Hengrui Medicine Co.,Ltd. (江苏恒瑞医药股份有限公司) (600276.SH) reported a net profit of 1.2 billion yuan in the first quarter of 2023, up 2.1% year-on-year.

Meanwhile, the company posted 5.5 billion yuan in revenue, up 0.3% year-on-year.

At the end of the reporting period, it had 42.3 billion yuan in total assets and 2.8 billion yuan in total liabilities, with a liability-to-asset ratio of 6.7%.